Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
1.2.1. Cell and Gene therapy Manufacturing Services Market, by region, 2019-2027 (USD Million)
1.2.2. Cell and Gene therapy Manufacturing Services Market, by Type, 2019-2027 (USD Million)
1.2.3. Cell and Gene therapy Manufacturing Services Market, by Indication, 2019-2027 (USD Million)
1.2.4. Cell and Gene therapy Manufacturing Services Market, by Mode, 2019-2027 (USD Million)
1.2.5. Cell and Gene therapy Manufacturing Services Market, by End user, 2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cell and Gene therapy Manufacturing Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cell and Gene therapy Manufacturing Services Market Dynamics
3.1. Cell and Gene therapy Manufacturing Services Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing investments of pharmaceutical companies in the Research & Development
3.1.1.2. Increase in the number of chronic diseases, orthopaedics and other cardiovascular diseases
3.1.2. Market Restraint
3.1.2.1. increasing in the operational costs
3.1.3. Market Opportunities
3.1.3.1. increase in the number of clinical therapies for cell and gene therapies
Chapter 4. Global Cell and Gene therapy Manufacturing Services Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cell and Gene therapy Manufacturing Services Market, by Type
5.1. Market Snapshot
5.2. Global Cell and Gene therapy Manufacturing Services Market by Type, Performance - Potential Analysis
5.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Type 2018-2027 (USD Million)
5.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
5.4.1. Cell
5.4.2. Gene
Chapter 6. Global Cell and Gene therapy Manufacturing Services Market, by Indication
6.1. Market Snapshot
6.2. Global Cell and Gene therapy Manufacturing Services Market by Indication, Performance - Potential Analysis
6.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Indication 2018-2027 (USD Million)
6.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Cardiology
6.4.3. Orthopaedic
6.4.4. Others
Chapter 7. Global Cell and Gene therapy Manufacturing Services Market, by Mode
7.1. Market Snapshot
7.2. Global Cell and Gene therapy Manufacturing Services Market by Mode, Performance - Potential Analysis
7.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by Mode 2018-2027 (USD Million)
7.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
7.4.1. In house manufacturing
7.4.2. Contract manufacturing
Chapter 8. Global Cell and Gene therapy Manufacturing Services Market, by End user industry
8.1. Market Snapshot
8.2. Global Cell and Gene therapy Manufacturing Services Market by End user industry, Performance - Potential Analysis
8.3. Global Cell and Gene therapy Manufacturing Services Market Estimates & Forecasts by End user industry 2018-2027 (USD Million)
8.4. Cell and Gene therapy Manufacturing Services Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Biotechnology companies
8.4.2. Academic and research institute
Chapter 9. Global Cell and Gene therapy Manufacturing Services Market, Regional Analysis
9.1. Cell and Gene therapy Manufacturing Services Market, Regional Market Snapshot
9.2. North America Cell and Gene therapy Manufacturing Services Market
9.2.1. U.S. Cell and Gene therapy Manufacturing Services Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Indication breakdown estimates & forecasts, 2018-2027
9.2.1.3. Mode breakdown estimates & forecasts, 2018-2027
9.2.1.4. End User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Cell and Gene therapy Manufacturing Services Market
9.3. Europe Cell and Gene therapy Manufacturing Services Market Snapshot
9.3.1. U.K. Cell and Gene therapy Manufacturing Services Market
9.3.2. Germany Cell and Gene therapy Manufacturing Services Market
9.3.3. France Cell and Gene therapy Manufacturing Services Market
9.3.4. Spain Cell and Gene therapy Manufacturing Services Market
9.3.5. Italy Cell and Gene therapy Manufacturing Services Market
9.3.6. Rest of Europe Cell and Gene therapy Manufacturing Services Market
9.4. Asia-Pacific Cell and Gene therapy Manufacturing Services Market Snapshot
9.4.1. China Cell and Gene therapy Manufacturing Services Market
9.4.2. India Cell and Gene therapy Manufacturing Services Market
9.4.3. Japan Cell and Gene therapy Manufacturing Services Market
9.4.4. Australia Cell and Gene therapy Manufacturing Services Market
9.4.5. South Korea Cell and Gene therapy Manufacturing Services Market
9.4.6. Rest of Asia Pacific Cell and Gene therapy Manufacturing Services Market
9.5. Latin America Cell and Gene therapy Manufacturing Services Market Snapshot
9.5.1. Brazil Cell and Gene therapy Manufacturing Services Market
9.5.2. Mexico Cell and Gene therapy Manufacturing Services Market
9.6. Rest of The World Cell and Gene therapy Manufacturing Services Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Thermo fisher Scientific Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Merck KGaA
10.2.3. Charles River Laboratories
10.2.4. Lonza
10.2.5. Catalent, Inc.
10.2.6. Takara Bio Inc.
10.2.7. Fujifilm Holdings Corporation
10.2.8. Roche Ltd
10.2.9. Wuxi Advanced Therapies
10.2.10. Cell and Gene Therapy Catapult
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption